ICN Pharmaceuticals Inc. has again extended its offer to buy drug-maker Ribapharm Inc. until 1 August 2003 and emphasized that shareholders should not expect its $168 million bid to be sweetened.
As of July 29, when the offer was set to expire, about 7.7 million Ribapharm shares were tendered for the offer of $5.60 a share and not withdrawn, ICN said.
ICN, based in Costa Mesa, California, said it intends to terminate the offer 1 August if not enough shares are tendered. ICN already owns 80 percent of Ribapharm, whose directors have urged shareholders to reject the bid, saying it is too low.
Find Dragon Pharma Steroids
Dragon Pharma is manufacturing a wide range of steroids Winstrol 50mg.